DK183583D0 - METHOD FOR PREPARING BENZOAZACYCLOALKYL-SPIRO-IMIDAZOLIDINES - Google Patents

METHOD FOR PREPARING BENZOAZACYCLOALKYL-SPIRO-IMIDAZOLIDINES

Info

Publication number
DK183583D0
DK183583D0 DK1835/83A DK183583A DK183583D0 DK 183583 D0 DK183583 D0 DK 183583D0 DK 1835/83 A DK1835/83 A DK 1835/83A DK 183583 A DK183583 A DK 183583A DK 183583 D0 DK183583 D0 DK 183583D0
Authority
DK
Denmark
Prior art keywords
benzoazacycloalkyl
imidazolidines
spiro
preparing
preparing benzoazacycloalkyl
Prior art date
Application number
DK1835/83A
Other languages
Danish (da)
Other versions
DK183583A (en
Inventor
Charles Malen
Jean-Louis Peglion
Jacques Duhault
Michelle Boulanger
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of DK183583D0 publication Critical patent/DK183583D0/en
Publication of DK183583A publication Critical patent/DK183583A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK183583A 1982-04-27 1983-04-26 PROCEDURE FOR PREPARING BENZOAZACYCLOALKYL-SPIRO-IMIDAZOLIDINES DK183583A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8207203A FR2525603A1 (en) 1982-04-27 1982-04-27 BENZOAZACYCLOALKYL-SPIRO-IMIDAZOLININES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR8207203 1982-04-27

Publications (2)

Publication Number Publication Date
DK183583D0 true DK183583D0 (en) 1983-04-26
DK183583A DK183583A (en) 1983-10-28

Family

ID=9273425

Family Applications (1)

Application Number Title Priority Date Filing Date
DK183583A DK183583A (en) 1982-04-27 1983-04-26 PROCEDURE FOR PREPARING BENZOAZACYCLOALKYL-SPIRO-IMIDAZOLIDINES

Country Status (22)

Country Link
JP (1) JPS5910584A (en)
KR (1) KR840004428A (en)
AT (1) ATA125383A (en)
AU (1) AU1395383A (en)
BE (1) BE896572A (en)
DD (1) DD209833A5 (en)
DE (1) DE3315106A1 (en)
DK (1) DK183583A (en)
ES (1) ES521895A0 (en)
FR (1) FR2525603A1 (en)
GB (1) GB2133401B (en)
GR (1) GR78481B (en)
IL (1) IL68497A0 (en)
IT (1) IT1167123B (en)
LU (1) LU84770A1 (en)
MA (1) MA19783A1 (en)
NL (1) NL8301476A (en)
NO (1) NO831473L (en)
OA (1) OA07412A (en)
PT (1) PT76595B (en)
SE (1) SE8302347L (en)
ZA (1) ZA832927B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US4927831A (en) * 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
EP2189448B1 (en) 2003-06-17 2014-01-29 Arena Pharmaceuticals, Inc. Processes for the Separation of 3-Benzazepine Racemates
CN101792417A (en) 2003-06-17 2010-08-04 艾尼纳制药公司 Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
KR101281919B1 (en) 2004-12-21 2013-07-03 아레나 파마슈티칼스, 인크. Crystalline forms of (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
PT1833473E (en) 2004-12-23 2009-12-17 Arena Pharm Inc 5ht2c receptor modulator compositions and methods of use
EP2001852A2 (en) 2006-04-03 2008-12-17 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
CA2670285A1 (en) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
JP5491421B2 (en) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ, インコーポレイテッド Process for the preparation of intermediates related to the 5-HT2C agonist (R) -8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
CN102648170A (en) 2009-06-18 2012-08-22 艾尼纳制药公司 Processes for the preparation of 5-HT2C receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
EP2939677A1 (en) 2010-09-01 2015-11-04 Arena Pharmaceuticals, Inc. Administration of lorcaserin to indviduals with renal impairment
CN103189360A (en) 2010-09-01 2013-07-03 艾尼纳制药公司 Non-hygroscopic salts of 5-HT2C agonists
ES2704455T3 (en) 2010-09-01 2019-03-18 Arena Pharm Inc Pharmaceutical forms of modified release of 5-HT2C agonists useful for weight management
WO2012030938A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
AU2012392187B2 (en) 2012-10-09 2018-07-12 Arena Pharmaceuticals, Inc. Method of weight management

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
ES8405796A1 (en) 1984-06-16
SE8302347L (en) 1983-10-28
IT1167123B (en) 1987-05-13
ES521895A0 (en) 1984-06-16
GB2133401A (en) 1984-07-25
PT76595B (en) 1986-01-21
DD209833A5 (en) 1984-05-23
ATA125383A (en) 1986-05-15
KR840004428A (en) 1984-10-15
LU84770A1 (en) 1984-11-28
JPS5910584A (en) 1984-01-20
PT76595A (en) 1983-05-01
SE8302347D0 (en) 1983-04-26
IL68497A0 (en) 1983-07-31
OA07412A (en) 1984-11-30
NL8301476A (en) 1983-11-16
ZA832927B (en) 1984-06-27
AU1395383A (en) 1983-11-03
IT8348155A0 (en) 1983-04-26
NO831473L (en) 1983-10-28
FR2525603B1 (en) 1984-09-14
GB8311508D0 (en) 1983-06-02
DK183583A (en) 1983-10-28
GB2133401B (en) 1985-10-23
BE896572A (en) 1983-10-26
DE3315106A1 (en) 1983-11-03
GR78481B (en) 1984-09-27
FR2525603A1 (en) 1983-10-28
MA19783A1 (en) 1983-12-31

Similar Documents

Publication Publication Date Title
DK470583D0 (en) METHOD FOR PREPARING 1-PHENYL-2-PIPERIDINOPROPANOL DERIVATIVES
DK280182A (en) METHOD FOR PREPARING N-ARYL-PIPERAZINAL CANAMIDES
DK350083D0 (en) PROCEDURE FOR PREPARING PHENYLETHANOLAMINES
DK492783D0 (en) METHOD FOR PREPARING 3-ARYL-5-PYRAZOLE DERIVATIVES
DK95483D0 (en) METHOD FOR PREPARING TETRA-HYDROPYRANE DERIVATIVES
DK183583D0 (en) METHOD FOR PREPARING BENZOAZACYCLOALKYL-SPIRO-IMIDAZOLIDINES
DK210083D0 (en) METHOD FOR PREPARING 6A, 10A-TRANS-HEXAHYDRODIBENZOPYRANONES
DK299483D0 (en) PROCEDURE FOR PREPARING N-PHOSPHONOMETHYLGYLINE
DK370582A (en) METHOD FOR PREPARING 2-BETA-D-RIBOFURANOSYLTHIAZOL-4-CARBOXAMIDE
DK283083A (en) PROCEDURE FOR PREPARING N-PHOSPHONOMETHYLGYLINE
DK159309C (en) METHOD FOR PREPARING 4-METHYL-5-ALKYLTHIOMETHYL-IMIDAZOLES
DK115581A (en) METHOD FOR PREPARING PYRIMIDYLQUINAZOLINES
DK40883D0 (en) METHOD FOR PREPARING BENZOTHIENYLALLYLAMINES
DK449881A (en) METHOD FOR PREPARING MOROXYDINPHENOXYISOBUTYRATES
DK394783A (en) PROCEDURE FOR PREPARING N-PHOSPHONOMETHYLGYLINE
DK361983A (en) PROCEDURE FOR PREPARING MELDROD ALCOALOIDS
DK399783A (en) METHOD FOR PREPARING SUBSTITUTED 1-PYRIDYLOXY-3-INDOLYLALKYLAMINO-2-PROPANOLS
DK518883A (en) METHOD FOR PREPARING 1-OXA-BETA-LACTAM COMPOUNDS
DK457983D0 (en) METHOD FOR PREPARING BETA-LACTAM
DK385983D0 (en) PROCEDURE FOR PREPARING 1-OXACEPHAMER
DK432683D0 (en) METHOD FOR PREPARING 2-HYDROXY-2-PHENYLETHYLAMINES
DK156061C (en) METHOD FOR PREPARING 2-ALKYL-4-AMINO-5-AMINOMETHYLPYRIMIDINE
DK400481A (en) METHOD FOR PREPARING 4-CARBAMOYLOXY-OXAZAPHOSPORINES
DK9383D0 (en) PROCEDURE FOR PREPARING PHOSPHINOXIDES
DK99582A (en) METHOD FOR PREPARING 4-FLUORAZETIDINONES

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment